SeekingAlpha · Oct 1, 2026
Terumo Corporation (TRUMY) Arsenal Medical, Inc. - M&A Call - Slideshow
2026-10-01. The following slide deck was published by Terumo Corporation in conjunction with this event.
TR
OTC · TRUMY
Terumo Corporation
Healthcare · Medical - Instruments & Supplies
$14.28
Up+$1.03 (+7.74%)
Updated Oct 10, 2026, 9:03 PM
SID Score
4.5/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 21.8B
- P/E ratio
- 26.1
- Dividend yield
- 1.26%
- 52-week range
- $12.08 – $17.81
- Volume
- 116.5K
- Avg. volume
- 200.16K
Price performance · TRUMY
TRUMY price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
TRUMY closed at $13.25 after 20 trading sessions, down 9.15% for the selected period.
- Last close
- $13.25
- Period change
- -9.15%
- Period low
- $13.25
- Period high
- $14.72
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $13.92 | $13.92 | $12.91 | $13.2545 | 116.5K |
| Oct 7, 2026 | $14.31 | $14.68 | $14.31 | $14.67 | 61.02K |
| Oct 6, 2026 | $14.17 | $14.72 | $14.17 | $14.66 | 110.18K |
| Oct 5, 2026 | $14.36 | $14.47 | $14.36 | $14.44 | 95.3K |
| Oct 2, 2026 | $14.21 | $14.292 | $14.18 | $14.21 | 50.14K |
| Oct 1, 2026 | $14.78 | $14.88 | $14.51 | $14.72 | 122.67K |
| Sep 30, 2026 | $14.11 | $14.7084 | $14.11 | $14.39 | 62.74K |
| Sep 29, 2026 | $14.264 | $14.55 | $14.12 | $14.44 | 67.63K |
| Sep 28, 2026 | $14.56 | $14.564 | $14.50 | $14.52 | 97.18K |
| Sep 25, 2026 | $14.27 | $14.80 | $14.20 | $14.59 | 69.14K |
| Sep 24, 2026 | $14.296 | $14.335 | $14.26 | $14.26 | 125.61K |
| Sep 23, 2026 | $14.3345 | $14.38 | $14.05 | $14.10 | 69.95K |
| Sep 22, 2026 | $14.18 | $14.35 | $14.05 | $14.19 | 82.77K |
| Sep 21, 2026 | $13.68 | $14.383 | $13.68 | $14.19 | 93.64K |
| Sep 18, 2026 | $14.1675 | $14.3328 | $13.90 | $14.16 | 71.65K |
| Sep 17, 2026 | $14.66 | $14.78 | $14.588 | $14.68 | 83.4K |
| Sep 16, 2026 | $14.565 | $14.5815 | $14.33 | $14.37 | 45.99K |
| Sep 15, 2026 | $14.11 | $14.44 | $14.11 | $14.425 | 92.28K |
| Sep 14, 2026 | $14.709 | $14.709 | $14.58 | $14.66 | 80.59K |
| Sep 11, 2026 | $13.9901 | $14.65 | $13.9901 | $14.59 | 67.36K |
Latest TRUMY news
The latest Smart Investors Daily articles mentioning TRUMY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
TRUMY research
Overview
Company profile and research snapshot.
Company profile
TERUMO CORP UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Sep 29, 2026
Terumo Corp's Dividend Analysis
This article first appeared on GuruFocus. Terumo Corp (TRUMF) recently announced a total dividend of $0.11 per share, with the ex-dividend date set for September 29, 2026. This upcoming distribution consists entirely of a $0.11 per share cash dividend, though the specific payable date has not yet been confirmed by the company.
Yahoo · Sep 18, 2026
Interventional Cardiology Devices Market by Type, End User - Global Forecast to 2031
The global interventional cardiology devices market is forecast to grow from USD 31.12 billion in 2026 to USD 42.39 billion by 2031, at a 6.4% CAGR. Growth is driven by rising cardiovascular disease, aging populations, demand for minimally invasive procedures, better healthcare access, and advances in stents, imaging and catheter technologies. Plain angioplasty balloons, embolic protection devices, guidewires and hospitals will see strong growth, while Asia Pacific is set to be the fastest-growi
SeekingAlpha · Aug 12, 2026
Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks Transcript
Terumo Corporation (TRUMY) Q1 2027 Earnings Call August 7, 2026 4:00 AM EDTCompany ParticipantsJin Hagimoto - CFO, CIO, GM of Accounting, Corporate...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
